Results 171 to 180 of about 9,435 (185)

Heterologous prime-boost immunization of two-component vaccine candidate PWDVax protected pigs against F18 enterotoxigenic <i>Escherichia coli</i> post-weaning diarrhea. [PDF]

Infect Immun
Zhang C, Li S, Upadhyay I, Vakamalla SSR, Lauder KL, Hansen C, Massey KA, Hayes C, Herndon NL, Zhang W.   +9 more
europepmc   +1 more source

Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice. [PDF]

Sci Transl Med
Cottrell CA, Hu X, Lee JH, Skog P, Luo S, Flynn CT, McKenney KR, Hurtado J, Kalyuzhniy O, Liguori A, Willis JR, Landais E, Raemisch S, Chen X, Baboo S, Himansu S, Diedrich JK, Duan H, Cheng C, Schiffner T, Bader DLV, Kulp DW, Tingle R, Georgeson E, Eskandarzadeh S, Alavi N, Lu D, Sincomb T, Kubitz M, Mullen TM, Yates JR, Paulson JC, Mascola JR, Alt FW, Briney B, Sok D, Schief WR.   +36 more
europepmc   +1 more source

Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand. [PDF]

Vaccine X
Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J.   +9 more
europepmc   +1 more source

Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice. [PDF]

Int J Nanomedicine
Li D, Bian L, Cui L, Zhou J, Li G, Zhao X, Xing L, Cui J, Sun B, Jiang C, Kong W, Zhang Y, Chen Y.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model

Vaccine, 2010
Preparation for an H5N1 influenza pandemic in humans may involve priming the population with a vaccine produced from an existing, available H5N1 strain. We have used a mouse challenge model to compare the immunogenicity and efficacy of inactivated, Vero cell-derived, whole virus H5N1 vaccines in single immunization and homologous or heterologous prime ...
Nicolas Sabarth, Helga Savidis-Dacho, P Noel Barrett   +2 more
exaly   +3 more sources

A prime–boost vaccination of mice with heterologous H5N1 strains

Vaccine, 2009
We evaluated the priming effect of an H5N1 pandemic vaccine in a mouse model to investigate strategies for influenza pandemic vaccination. For priming, an alum-adjuvanted inactivated whole H5N1 vaccine (NIBRG-14, clade 1) was used. As booster vaccines, several formulations of Indo05/05/2005(H5N1)PR8-IBCDC-RG2 vaccines (clades 2-1)were evaluated ...
Daisuke, Ikeno, Kazuhiko, Kimachi, Yasuhiro, Kudo, Shuro, Goto, Shigeyuki, Itamura, Takato, Odagiri, Masato, Tashiro, Yoichiro, Kino   +7 more
openaire   +2 more sources

Heterologous Prime-Boost Immunizations with a Virosomal and an Alphavirus Replicon Vaccine

Molecular Pharmaceutics, 2010
Heterologous prime-boost immunization strategies in general establish higher frequencies of antigen-specific T lymphocytes than homologous prime-boost protocols or single immunizations. We developed virosomes and recombinant Semliki Forest virus (rSFV) as antigen delivery systems, each capable of inducing strong CTL responses in homologous prime-boost ...
Walczak, Mateusz, de Mare, Arjan, Riezebos-Brilman, Annelies, Regts, Joke, Hoogeboom, Baukje-Nynke, Visser, Jeroen T., Fiedler, Marc, Jansen-Duerr, Pidder, van der Zee, Ate G. J., Nijman, Hans W., Wilschut, Jan, Daemen, Toos   +11 more
openaire   +3 more sources

Heterologous Prime-Boost Vaccination in Tumor Immunotherapy

2004
Most of the vaccine strategies under development use multiple immunizations with the same agent such as a viral vector encoding a tumor antigen. More recently, the concept of heterologous prime-boost immunization has been tested in animal models. This strategy involves the sequential administration of different delivery vectors encoding the same ...
Michael J. Palmowski, Caroline Smith
openaire   +1 more source

Effect of homologous and heterologous prime–boost on the immune response to recombinant plague antigens

Vaccine, 2005
Among the pathogens that have been identified as potential agents of biological warfare or bioterrorism, Yersinia pestis is one of the main concerns due to the severity and potential transmissibility of the pneumonic form of the disease in humans. There are no approved vaccines for protection against pneumonic plague, but a Y.
Audrey, Glynn, Lucy C, Freytag, John D, Clements   +2 more
openaire   +2 more sources

Superior protection against paratuberculosis by a heterologous prime-boost immunization in a murine model

Vaccine
Vaccination is the best strategy to control Paratuberculosis (PTB), which is a significant disease in cattle and sheep. Previously we showed the humoral and cellular immune response induced by a novel vaccine candidate against PTB based on the Argentinian Mycobacterium avium subspecies paratuberculosis (Map) 6611 strain.
María Alejandra, Colombatti Olivieri, María Ximena, Cuerda, Roberto Damián, Moyano, María José, Gravisaco, María Fiorella Alvarado, Pinedo, Fernando Oscar, Delgado, Gabriela, Calamante, Silvia, Mundo, María, de la Paz Santangelo, María Isabel, Romano, María Natalia, Alonso, María Paula, Del Medico Zajac   +11 more
openaire   +2 more sources